2 型乳头状肾细胞癌的临床试验
总计7449个结果
-
Washington University School of MedicineNational Cancer Institute (NCI)完全的
-
Stanford UniversityNational Comprehensive Cancer Network完全的
-
Genentech, Inc.撤销
-
Astellas Pharma IncOSI Pharmaceuticals完全的
-
AVEO Pharmaceuticals, Inc.Astellas Pharma Inc终止
-
Kidney Cancer Research Bureau完全的
-
Radboud University Medical CenterABX CRO; Telix International Pty Ltd完全的
-
M.D. Anderson Cancer CenterNovartis完全的
-
Stanford UniversitySiemens Healthcare QT完全的
-
Institut Claudius RegaudUniversity Hospital, Bordeaux完全的
-
Royal Marsden NHS Foundation Trust未知
-
Sandy SrinivasNovartis; Genentech, Inc.终止
-
Central European Cooperative Oncology Group终止
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Exelixis主动,不招人
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...主动,不招人
-
Eli Lilly and Company完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Elypta招聘中透明细胞肾细胞癌美国, 瑞典, 英国, 法国, 丹麦, 芬兰, 加拿大, 意大利, 葡萄牙, 西班牙
-
National Cancer Institute (NCI)完全的
-
Massachusetts General HospitalGlaxoSmithKline完全的
-
Weill Medical College of Cornell University终止
-
Telix International Pty LtdGrand Pharmaceutical (China) Co., Ltd.完全的
-
Spanish Oncology Genito-Urinary GroupPfizer; Apices Soluciones S.L.完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Beth Israel Deaconess Medical CenterNovartis; Dana-Farber Cancer Institute; Duke University完全的
-
RenJi HospitalShanghai Zhongshan Hospital尚未招聘非透明肾细胞癌的一线治疗